跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Nasamed - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Nasamed
Approved
STANDARD
Nasamed
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
563f0912b3960e12
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
563f0912b3960e12
Drug Approval Philippines Name
Nasamed
Product Name
Nasamed
Registration Number
DRP-2122-02
Brand Name
Nasamed
Generic Name
Guaifenesin + Salbutamol (as sulfate)
Dosage Form
Capsule
Dosage Strength
100 mg/2 mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
Interhealthcare Pharmaceuticals, Inc.
Distributor
Altomed Pharmaceuticals, Inc.
Issuance Date
26 May 2022
Expiry Date
12 July 2027
Pharmacologic Category
Expectorant/Bronchodilator
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
563f0912b3960e12
Type
Standard
Back to Philippines FDA Approvals